Pathogenicity and neurovirulence of a mutagen-attenuated Rift Valley fever vaccine in rhesus monkeys

By Morrill J.C.   Peters C.J.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2994-3002

Elsevier

Access to resources Recommend Favorite

Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children

By Castillo de Febres O.   Chacon de Petrola M.   Casanova de Escalona L.   Naveda O.   Naveda M.   Estopinan M.   Bordones G.   Zambrano B.   Garcia A.   Dumas R.  

Vaccine, Vol. 18, Iss. 7, 1999-11 ,pp. : 656-664

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine

By Dagan R.   Greenberg D.   Goldenbertg-Gehtman P.   Vidor E.   Briantais P.   Pinsk V.   Athias O.   Dumas R.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1919-1925

Elsevier

Access to resources Recommend Favorite

The immunogenicity in humans of a botulinum type F vaccine

By Montgomery V.A.   Makuch R.S.   Brown J.E.   Hack D.C.  

Vaccine, Vol. 18, Iss. 7, 1999-11 ,pp. : 728-735

Elsevier

Access to resources Recommend Favorite

Immunogenicity of an inactivated hepatitis A vaccine in Dutch United Nations troops

By Buma A.P.C.C.H.   van Doornum G.J.J.   Veltink R.L.   van Ameijden E.J.C.   Leentvaar-Kuijpers A.   Coutinho R.A.  

Vaccine, Vol. 15, Iss. 12, 1997-08 ,pp. : 1413-1417

Elsevier

Access to resources Recommend Favorite